Artelo Biosciences, Inc. (ARTL) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Artelo Biosciences, Inc. (ARTL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Artelo Biosciences, Inc., the average estimate for 2030 earnings per share is $365.58; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Artelo Biosciences, Inc. (ARTL) forecast — frequently asked questions
What are analysts forecasting for Artelo Biosciences, Inc.'s earnings?
The average analyst estimate for Artelo Biosciences, Inc. (ARTL) earnings per share in 2030 is 365.58, with individual estimates between 365.58 and 365.58.
How much revenue is Artelo Biosciences, Inc. expected to make?
Analysts forecast Artelo Biosciences, Inc. (ARTL) revenue of $245.29M in 2030, based on 1 published estimates.
How many analysts cover ARTL?
1 analyst contribute estimates for Artelo Biosciences, Inc. (ARTL). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.